175 related articles for article (PubMed ID: 30007638)
1. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy.
Zhuo F; Abourehab MAS; Hussain Z
Carbohydr Polym; 2018 Oct; 197():478-489. PubMed ID: 30007638
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
[TBL] [Abstract][Full Text] [Related]
3. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting.
Md S; Kuldeep Singh JKA; Waqas M; Pandey M; Choudhury H; Habib H; Hussain F; Hussain Z
Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554
[TBL] [Abstract][Full Text] [Related]
4. Skin targeting by chitosan/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis model.
Abuelella KE; Abd-Allah H; Soliman SM; Abdel-Mottaleb MMA
Int J Biol Macromol; 2023 Mar; 232():123458. PubMed ID: 36709804
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Yu K; Wang Y; Wan T; Zhai Y; Cao S; Ruan W; Wu C; Xu Y
Int J Nanomedicine; 2018; 13():129-142. PubMed ID: 29317821
[TBL] [Abstract][Full Text] [Related]
6. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis.
Siddique MI; Katas H; Amin MC; Ng SF; Zulfakar MH; Jamil A
Int J Pharm; 2016 Jun; 507(1-2):72-82. PubMed ID: 27154252
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis.
Pople PV; Singh KK
Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619
[TBL] [Abstract][Full Text] [Related]
8. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy.
Pople PV; Singh KK
Int J Pharm; 2012 Sep; 434(1-2):70-9. PubMed ID: 22609427
[TBL] [Abstract][Full Text] [Related]
9. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
10. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis.
Pople PV; Singh KK
Int J Pharm; 2010 Oct; 398(1-2):165-78. PubMed ID: 20637847
[TBL] [Abstract][Full Text] [Related]
11. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
[TBL] [Abstract][Full Text] [Related]
12. Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery.
Pan W; Qin M; Zhang G; Long Y; Ruan W; Pan J; Wu Z; Wan T; Wu C; Xu Y
Int J Nanomedicine; 2016; 11():4037-50. PubMed ID: 27578973
[TBL] [Abstract][Full Text] [Related]
13. A new strategy for the passive skin delivery of nanoparticulate, high molecular weight hyaluronic acid prepared by a polyion complex method.
Tokudome Y; Komi T; Omata A; Sekita M
Sci Rep; 2018 Feb; 8(1):2336. PubMed ID: 29403004
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review.
How KN; Yap WH; Lim CLH; Goh BH; Lai ZW
Front Pharmacol; 2020; 11():1105. PubMed ID: 32848737
[TBL] [Abstract][Full Text] [Related]
15. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
[TBL] [Abstract][Full Text] [Related]
16. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
17. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Analysis of Human Skin Distribution and Follicular Targeting of Adapalene-Loaded Biodegradable Nanospheres With an Insight Into Hydrogel Matrix Influence, In Vitro Skin Irritation, and In Vivo Tolerability.
Sallam MA; Marín Boscá MT
J Pharm Sci; 2017 Oct; 106(10):3140-3149. PubMed ID: 28603018
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.
Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Buang F; Sahudin S
Int J Pharm; 2013 Feb; 444(1-2):109-19. PubMed ID: 23337632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
